• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

AbbVie to Buy Pharmacyclics for $21 Billion

Article

March 5, 2015.

AbbVie Inc. (North Chicago, IL) is to buy Pharmacyclics (Sunnyvale, CA) for "about $21 billion", Reuters reports today.

The deal will give AbbVie access to what is expected to be one of the world's top-selling cancer drugs: Pharmacyclics' blood cancer treatment Imbruvica is predicted to hit $1 billion in US sales this year, with worldwide sales to reach $5.8 billion by 2020, according to Thomson Reuters Cortellis.

 

 

Recent Videos
Related Content
Gaugarin Oliver

AI in Pharma: Where, When, and How Executives are Considering it

Gaugarin Oliver
November 19th 2024
Article

As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems

Mike Hollan
November 15th 2024
Article

Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.

The Leap Forward: Practical Gains for Pharma AI Use

The Leap Forward: Practical Gains for Pharma AI Use

Bianca Anghelina;Helen Merianos;Ruth Beadle
November 14th 2024
Article

Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.

Abby Reynolds

The Rise of Digital Platforms: Q&A with Abby Reynolds

Mike Hollan
November 14th 2024
Article

Pleio’s chief experience officer discusses why these platforms are being embraced by the industry.

Passage to Asia: Early Access for Innovative Therapies

Passage to Asia: Early Access for Innovative Therapies

Bruce Liu
November 13th 2024
Article

Pharma looks to take advantage of expanded access programs across Asia-Pacific region.

Becky Upton

Security and Data Sharing: Q&A with The Pistoia’s Alliance’s Dr. Becky Upton

Mike Hollan
October 30th 2024
Article

The alliance’s president discusses the current state of data sharing, security concerns, and the adoption AI.